READ MORE drugs and medical devices LEGAL NEWS
One gynecologist, Dr. Sebastiaan Veersema, Antonius Hospital Nieuwegein in the Netherlands, who was an early adopter of Essure and has implanted the contraceptive device in to nearly 1,400 women, now believes it requires further study. He says they need to establishe what, if any relationship exists between the side effects patients are reporting and the device itself. and the problems relayed by some patients.
The independent expert panel has come together at the request of the Food and Drug Administration (FDA) to discuss possible labeling changes to the product and whether additional clinical studies should be done. The panel will not be asked to formally vote on their recommendations.